Search Results

Profiling of Early Immune Responses to Vaccination Using THP-1-Derived Dendritic Cells.

• Authors : Ye, Lei^1,2 (AUTHOR) ; Li, Ping¹ (AUTHOR) ; Wang, Mingzhe¹ (AUTHOR)

Subjects: *DENDRITIC cells; *IMMUNE response; *MONONUCLEAR leukocytes

• Source: International Journal of Molecular Sciences. May2024, Vol. 25 Issue 10, p5509. 14p.

Record details

Efficacy, immunogenicity and safety of respiratory syncytial virus prefusion F vaccine: systematic review and meta-analysis.

• Authors : Pang, Yi¹ (AUTHOR); Lu, Haishan^2,3 (AUTHOR); Cao, Demin^2,3 (AUTHOR)

Subjects: *RESPIRATORY syncytial virus; *IMMUNE response; *VACCINE effectiveness

• Source: BMC Public Health. 5/6/2024, Vol. 24 Issue 1, p1-13. 13p.

Record details

Helminth exposure and immune response to the two-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccine regimen.

• Authors : Barry, Houreratou^1,2 (AUTHOR); Lhomme, Edouard^2,3,4 (AUTHOR); Surénaud, Mathieu^4,5 (AUTHOR)

• Source: PLoS Neglected Tropical Diseases. 4/11/2024, Vol. 18 Issue 4, p1-16. 16p.

Record details

Immune Cells, Gut Microbiota, and Vaccines: A Gender Perspective.

• Authors : Rio, Pierluigi¹ (AUTHOR) ; Caldarelli, Mario¹ (AUTHOR) ; Chiantore, Monica¹ (AUTHOR)

• Source: Cells (2073-4409). Mar2024, Vol. 13 Issue 6, p526. 26p.

Record details

Vaccination against Rhipicephalus microplus: an alternative to chemical control?

• Authors : Dedavid e. Silva, Lucas Andre¹; Ali, Abid²; Termignoni, Carlos³

Subjects: *RHIPICEPHALUS; *IXODIDAE; *FERRITINBRAZIL

• Source: Ciência Rural. 2024, Vol. 54 Issue 3, p1-15. 15p.

Record details

The Adaptive Immune Response against Bunyavirales.

• Authors : Alatrash, Reem^1,2 (AUTHOR); Herrera, Bobby Brooke^1,2 (AUTHOR)

Subjects: *IMMUNE response; *T cells; *VACCINE effectiveness

• Source: Viruses (1999-4915). Mar024, Vol. 16 Issue 3, p483. 32p.

Record details

Interim Estimates of 2023-24 Seasonal Influenza Vaccine Effectiveness--United States.

• Authors : Frutos, Aaron M.^1,2 ; Price, Ashley M.¹; Harker, Elizabeth¹

Subjects: *MEDICAL research; *INFLUENZA vaccines; *VACCINE effectivenessUNITED States

• Source: MMWR: Morbidity & Mortality Weekly Report. 2/29/2024, Vol. 73 Issue 8, p168-174. 7p.

Record details

Interim Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years--VISION and IVY Networks, September 2023-January 2024

Subjects: *MEDICAL research; *COVID-19 vaccines; *VACCINE effectiveness

• Source: MMWR: Morbidity & Mortality Weekly Report. 2/29/2024, Vol. 73 Issue 8, p180-188. 9p.

Record details

Interim Influenza Vaccine Effectiveness Against Laboratory-Confirmed Influenza--California, October 2023-January 2024.

• Authors : Zhu, Sophie^1,2 ; Quint, Joshua²; León, Tomás M.²

Subjects: *MEDICAL research; *INFLUENZA vaccines; *VACCINE effectivenessCALIFORNIA

• Source: MMWR: Morbidity & Mortality Weekly Report. 2/29/2024, Vol. 73 Issue 8, p175-179. 5p.

Record details

The spike protein of the apathogenic Beaudette strain of avian coronavirus can elicit a protective immune response against a virulent M41 challenge.

• Authors : Keep, Sarah¹ (AUTHOR) ; Stevenson-Leggett, Phoebe² (AUTHOR); Webb, Isobel³ (AUTHOR)

Subjects: *CHICKEN diseases; *CORONAVIRUSES; *AVIAN infectious bronchitis virus

• Source: PLoS ONE. 1/24/2024, Vol. 19 Issue 1, p1-22. 22p.

Record details